Abstract:Drug-resistant bacteria present a grave threat to human health. Photodynamic therapy (PDT) holds enormous potential as an innovative treatment in antimicrobial therapy. However, the generation of reactive oxygen species (ROS) for traditional photosensitizers in a hypoxic microenvironment or aggregated state is always restricted, limiting the antimicrobial effect. Herein, a cationization and cyano introduction molecular engineering strategy is reported to develop aggregation-induced emission active photosensitizers with enhanced type I ROS generation and bacteria binding ability for successful drug-resistant bacteria eradication. The introduction of a cyano group improves the light harvesting ability and ROS generation. This cationization can convert neutral molecules (TPAQ and CN-TPAQ) to their cationic counterparts (TPAQ-PF6 and CN-TPAQ-PF6), and enhance electron separation as well as transfer processes, which further promotes the ROS generation capacity, and in particular highly toxic hydroxyl radicals in aggregates that are 5.4-fold stronger than commercial crystal violet (CV) can be produced. As both the cationic charge and cyano group possess excellent bacterial binding affinity, the cationic CN-TPAQ-PF6 shows an excellent photodynamic killing efficiency of > 99.999999% toward MRSA and > 99.99999% toward S. aureus respectively at a very low concentration (2 mu M) and under low intensity daylight exposure (40 mW cm(-2)), and the antibacterial performance is superior to that of clinical vancomycin antibiotics. Furthermore, CN-TPAQ-PF6 is also successfully applied in bacteria sterilization in natural lake water. This work provides a powerful guide for the appropriate design of novel and efficient type I AIE PSs to effectively conquer antibiotic resistance.

Phage-Guided Targeting, Discriminative Imaging, and Synergistic Killing of Bacteria by AIE Bioconjugates

An AIEgen‐Peptide Conjugate As a Phototheranostic Agent for Phagosome‐Entrapped Bacteria

Photocatalytic Quantum Dot-Armed Bacteriophage for Combating Drug-Resistant Bacterial Infection

Harnessing antimicrobial peptide-coupled photosensitizer to combat drug-resistant biofilm infections through enhanced photodynamic therapy

Phospholipid-Mimetic Aggregation-Induced Emission Luminogens for Specific Elimination of Gram-Positive and Gram-Negative Bacteria.

Cationic AIE-active photosensitizers for highly efficient photodynamic eradication of drug-resistant bacteria

Light-Enhanced Bacterial Killing and Wash-Free Imaging Based on Aie Fluorogen

AIEgens for Bacterial Imaging and Ablation

Structure-oriented design strategy to construct NIR AIEgens to selectively combat gram (+) multidrug-resistant bacteria in vivo

Elaborately engineered Au(I)‐based AIEgens: Robust and broad‐spectrum elimination abilities toward drug‐resistant bacteria

Efficient Killing of Multidrug-Resistant Intracellular Bacteria by AIEgens in Vivo

Multifunctional AIE Nanosphere-Based "Nanobomb" for Trimodal Imaging-Guided Photothermal/Photodynamic/Pharmacological Therapy of Drug-Resistant Bacterial Infections

Amphiphilic AIE Fluorescent Probe: A Dual-Functionality Strategy for Efficient Antibacterial Therapy Fluorescence Bioimaging Against Staphylococcus Aureus

Aggregation-Induced Emission Nanoparticles for Single Near-Infrared Light-Triggered Photodynamic and Photothermal Antibacterial Therapy

AIE-based Theranostic Systems for Detection and Killing of Pathogens

Efficient Killing of Multidrug‐Resistant Internalized Bacteria by AIEgens In Vivo

Photodynamic and Photothermal Bacteria Targeting Nanosystems for Synergistically Combating Bacteria and Biofilms

Molecular docking-aided AIEgen design: concept, synthesis and applications

Guiding antibiotics towards their target using bacteriophage proteins

Precise Molecular Engineering of Type I Photosensitizers with Near‐Infrared Aggregation‐Induced Emission for Image‐Guided Photodynamic Killing of Multidrug‐Resistant Bacteria

Engineered Phage with Aggregation‐Induced Emission Photosensitizer in Cocktail Therapy against Sepsis (Adv. Mater. 6/2023)